Yesterday Stock’s Trend: Endo International plc (ENDP), ZIOPHARM Oncology, Inc. (ZIOP)

0
70

Endo International plc (ENDP):

Last Trade:

Endo International plc (ENDP) ended its previous trading session at $8.09 with the Loss of -1.04%. The company’s market cap is $1.83 Billion, and the average volume is $6.19 Million. The 52-Week High range of the stock is $15.47, while the 52-week low range is $5.77. The Price to Sales (P/S) of the stock is 0.46, while P/B (Price to Book) stands at 2.38. When we look at the Volatility of the company, Week Volatility is at 7.49% whereas Month Volatility is at 5.31%.

For the ongoing Fiscal Quarter, 8 analysts have an average earnings forecast of $0.7 per share. According to the Analysts, the Low Earnings estimate for the current quarter is $0.62, while the High earnings estimate is $0.78.Comparatively, EPS for the same quarter last year was $0.91.

According to 7 analysts, the Average Revenue Estimate for the current Fiscal quarter is $755.34 Million and the Low Revenue estimate is $728.99 Million, while the High Revenue estimate is $800.5 Million.

Endo International plc (ENDP) analysts on average have given a price target of $10.29 on ENDP stock.

According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 2.47 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.

ZIOPHARM Oncology, Inc. (ZIOP):

Previous Trade:

ZIOPHARM Oncology, Inc. (ZIOP) shares Jumped 0.2% and ended the day at $4.11. Its 52-week high and low range is between $7.88 and $3.77. The company’s outstanding shares are 141.96 Million. The volume of the company in the last trading session was 845231. The stock has a market cap of 582.75 Million. The Stock shows P/E value of 0 and Forward P/E of 0.

According to Finviz reported data, The SMA20 of the stock is at -3.04%, SMA50 is -6.25 percent, while SMA200 is -28.18%. The stock is currently has its Return on Assets (ROA) value of -62.8 Percent. The Return on Investment and Return on Equity (ROE) values are 213.9 percent and 88.2 percent, respectively.

The company’s ATR (Average True Range) is 0.28. The Weekly Volatility is 7.49% and the Monthly Volatility is 6.15%.

When we look at the Analyst Recommendations of the stock, the company has 2.2 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.

ZIOPHARM Oncology, Inc. (ZIOP) analysts on average have given a price target of $10.29 on ZIOP stock.

ZIOPHARM Oncology, Inc.’s Average Earnings Estimate for the current quarter is $-0.13, according to consensus of 4 analysts. The low EPS estimate is $-0.14, while the high EPS estimate is $-0.12.

Average Revenue Estimate of the company for the current Fiscal Quarter is $1.35 Million, according to consensus of 4 analysts. The higher end of the revenue estimate is $1.6 Million and the lower end is $750000.

LEAVE A REPLY